疾患特異的iPS細胞株。軟骨無形成症患者由来。HPS0523と同一人由来。プラスミドベクター(pCE-hOct3/4,pCE-hSK,pCE-hUL,pCE-mp53DD,pCXB-EBNA1）を用いて7因子(Oct3/4,Sox2,Klf4,L-Myc,LIN28,p53DD,EBNA1)を導入して樹立。<a href='https://cell.brc.riken.jp/ja/manual/vitrification' target="_blank">ガラス化法（Vitrification法）</a>保存。
1) 非営利機関以外の利用者は事前に<a href= 'http://ips-cell.net/j/index.php' target="_blank">iPSアカデミアジャパン株式会社 </a>から確認書を得ること。2) <a href='http://cell.brc.riken.jp/ja/wp-content/uploads/restriction/non-profit.pdf' target="_blank">別紙1 (非営利) </a>または<a href='http://cell.brc.riken.jp/ja/wp-content/uploads/restriction/profit.pdf' target="_blank">別紙1 (営利) </a>を提供同意書 (C-0003またはC-0003p) に添付すること。3) 利用者は、事前に承諾者から承諾を得ること。4) 先ずは、<a href="mailto:cellips.brc@riken.jp?subject=Disease specific iPS cell line 問い合わせ&">理研細胞バンク</a>にお問い合わせください 。
<a href="http://www.cira.kyoto-u.ac.jp/" target="_blank">http://www.cira.kyoto-u.ac.jp/</a>
CiRA00169
疾患特異的iPS細胞株。軟骨無形成症患者由来。HPS0523と同一人由来。プラスミドベクター(pCE-hOct3/4,pCE-hSK,pCE-hUL,pCE-mp53DD,pCXB-EBNA1）を用いて7因子(Oct3/4,Sox2,Klf4,L-Myc,LIN28,p53DD,EBNA1)を導入して樹立。<a href='http://cell.brc.riken.jp/ja/manual/vitrification' target="_blank">ガラス化法（Vitrification法）</a>保存。
Disease specific iPS cell line derived from a patient : Achondroplasia. HPS0523 was derived from the same patient. Order Form (C-0042, C-0057, C-0007 or C-0007p).
Disease specific iPS cell line derived from a patient : Achondroplasia. HPS0523 was derived from the same patient.
1) In relation to the for-profit organizations, please contact <a href= 'http://ips-cell.net/e/index.php' target="_blank">iPS Academia Japan, Inc.</a>, prior to the utilization of iPS cells. 2) Attach <a href='http://cell.brc.riken.jp/en/wp-content/uploads/restriction/non-profit_en.pdf' target="_blank">TERMS and CONDITIONS (non-for-profit) </a> or <a href='http://cell.brc.riken.jp/en/wp-content/uploads/restriction/profit_en.pdf' target="_blank">TERMS and CONDITIONS (for-profit) </a> to MTA (C-0007 or C-0007p) . 3) The RECIPIENT agrees to obtain the prior written approval of the distribution from the APPROVER. 4) Contact Us : <a href="mailto:cellips.brc@riken.jp?subject=Disease specific iPS cell line&">RIKEN Cell Bank</a>
HPS0522